Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
15.52
22.07
|
Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Shanghai Pharmaceuticals Holding Co Ltd
Other Long-Term Assets
Shanghai Pharmaceuticals Holding Co Ltd
Other Long-Term Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Other Long-Term Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
Other Long-Term Assets
ÂĄ2.4B
|
CAGR 3-Years
1%
|
CAGR 5-Years
1%
|
CAGR 10-Years
16%
|
||
Sinopharm Group Co Ltd
HKEX:1099
|
Other Long-Term Assets
ÂĄ5.1B
|
CAGR 3-Years
1%
|
CAGR 5-Years
8%
|
CAGR 10-Years
6%
|
||
Jointown Pharmaceutical Group Co Ltd
SSE:600998
|
Other Long-Term Assets
ÂĄ617.1m
|
CAGR 3-Years
12%
|
CAGR 5-Years
15%
|
CAGR 10-Years
25%
|
||
C
|
China National Medicines Corp Ltd
SSE:600511
|
Other Long-Term Assets
ÂĄ914.9m
|
CAGR 3-Years
63%
|
CAGR 5-Years
33%
|
CAGR 10-Years
20%
|
|
Huadong Medicine Co Ltd
SZSE:000963
|
Other Long-Term Assets
ÂĄ1.8B
|
CAGR 3-Years
31%
|
CAGR 5-Years
14%
|
CAGR 10-Years
31%
|
||
C
|
China National Accord Medicines Corp Ltd
SZSE:000028
|
Other Long-Term Assets
ÂĄ1B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
16%
|
CAGR 10-Years
12%
|
Shanghai Pharmaceuticals Holding Co Ltd
Glance View
Shanghai Pharmaceuticals Holding Co Ltd, a giant in China's pharmaceutical industry, operates with a dual-engine strategy that seamlessly combines manufacturing and distribution. Established in the bustling metropolis of Shanghai, the company has swiftly become a cornerstone of China's healthcare landscape. Its manufacturing arm is a powerhouse of innovation and production, turning out a vast array of pharmaceutical products that encompass both traditional Chinese medicine and modern pharmaceuticals. These products range from patented medicines to essential generics, entering hospitals, clinics, and retail pharmacies nationwide, all the while feeding a robust supply chain that caters to the country's vast and diverse market needs. On the flip side, Shanghai Pharmaceuticals' extensive distribution network is the lifeline that ensures these vital medicines reach their destinations safely and efficiently. In an era where logistics and supply chain management are pivotal, the company excels through an advanced distribution system that connects manufacturers with end-users across China. This network is bolstered by strategic partnerships and a commitment to technological advancement, allowing the company to maintain agility and reliability in an ever-evolving market. Revenue streams flow not just from product sales but are heavily supplemented through strategic partnerships and services that enhance accessibility and affordability for healthcare providers and patients alike. As one of the top pharmaceutical firms in China, Shanghai Pharmaceuticals is adept at maneuvering the intricacies of healthcare demands, regulatory landscapes, and competitive dynamics, carving its niche as a leader in both innovation and distribution efficiency.
See Also
What is Shanghai Pharmaceuticals Holding Co Ltd's Other Long-Term Assets?
Other Long-Term Assets
2.4B
CNY
Based on the financial report for Sep 30, 2024, Shanghai Pharmaceuticals Holding Co Ltd's Other Long-Term Assets amounts to 2.4B CNY.
What is Shanghai Pharmaceuticals Holding Co Ltd's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 10Y
16%
Over the last year, the Other Long-Term Assets growth was -3%. The average annual Other Long-Term Assets growth rates for Shanghai Pharmaceuticals Holding Co Ltd have been 1% over the past three years , 1% over the past five years , and 16% over the past ten years .